pirenzepine has been researched along with Angor Pectoris in 2 studies
Pirenzepine: An antimuscarinic agent that inhibits gastric secretion at lower doses than are required to affect gastrointestinal motility, salivary, central nervous system, cardiovascular, ocular, and urinary function. It promotes the healing of duodenal ulcers and due to its cytoprotective action is beneficial in the prevention of duodenal ulcer recurrence. It also potentiates the effect of other antiulcer agents such as CIMETIDINE and RANITIDINE. It is generally well tolerated by patients.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lyzohub, VH | 1 |
| Pliskevyvch, DA | 1 |
| Nikoliuk, LS | 1 |
| Savchenko, OV | 1 |
| Marraccini, P | 1 |
| Orsini, E | 1 |
| Nassi, G | 1 |
| Michelassi, C | 1 |
| L'Abbate, A | 1 |
1 trial available for pirenzepine and Angor Pectoris
| Article | Year |
|---|---|
Usefulness of pirenzepine, an M1 antimuscarinic agent, for effort myocardial ischemia.
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Exercise Test; Female; Heart Rate; Humans; Isosorbide | 1992 |
1 other study available for pirenzepine and Angor Pectoris
| Article | Year |
|---|---|
[Gastrozepin therapy of gallbladder motility disorders in patients with ischemic heart disease].
Topics: Adult; Angina Pectoris; Anti-Ulcer Agents; Gallbladder Diseases; Gallbladder Emptying; Humans; Incid | 2002 |